Table 1.
Baseline characteristics of the study populations in the ANRS HB03 VIHVAC B trial and the ANRS 114-PNEUMOVAC sub-study.
Table 2.
Association between baseline 25OH Vitamin D status and response to hepatitis B vaccination in the ANRS HB03 VIHVAC B trial (n = 339).
Table 3.
Association between baseline 25OH Vitamin D level and antibody response to hepatitis B vaccination in the ANRS HB03 VIHVAC B trial (proportional logistic regression model, multivariable analysis, n = 333 with non missing covariates).
Table 4.
Correlations between baseline 25OHD level and change in cellular immune responses between W0 and W4 in the group having received the 7-valent conjugate vaccine prime containing the diphtheria-derived carrier protein CRM197 at W0, ANRS-114 PNEUMOVAC sub-study (n = 11).